These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1700141)

  • 1. Basophil releasability in severely burned patients.
    Bergmann U; König W; Gross-Weege W; Schlüter B; Köller M; Erbs G; Müller FE
    J Trauma; 1990 Nov; 30(11):1372-9. PubMed ID: 1700141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine release from basophils in cystic fibrosis.
    Schönfeld W; Saak A; Steinkamp G; Van der Hardt H; König W
    Clin Exp Immunol; 1989 Jun; 76(3):434-9. PubMed ID: 2473860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma.
    de Paulis A; Valentini G; Spadaro G; Lupoli S; Tirri G; Marone G
    Arthritis Rheum; 1991 Oct; 34(10):1289-96. PubMed ID: 1718285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
    Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
    Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human basophil releasability. I. Age-related changes in basophil releasability.
    Marone G; Poto S; di Martino L; Condorelli M
    J Allergy Clin Immunol; 1986 Feb; 77(2):377-83. PubMed ID: 2418093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.
    Tedeschi A; Arquati M; Lorini M; Milazzo N; Miadonna A
    Agents Actions; 1992 Sep; 37(1-2):16-24. PubMed ID: 1280906
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kowal K; Bielecki P; DuBuske IV; DuBuske LM
    Allergy Asthma Proc; 2017 May; 38(3):204-215. PubMed ID: 28441991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
    MacGlashan DW
    J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
    Marone G; Giugliano R; Lembo G; Ayala F
    J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LTB4-metabolism and histamine liberation by granulocytes in the disease pattern of cystic fibrosis (CF)].
    Saak A; Schönfeld W; König W; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):913-23. PubMed ID: 1722312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
    Gaddy JN; Busse WW
    Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
    Miadonna A; Leggieri E; Tedeschi A; Lazzarin A; Chianura L; Froldi M; Zanussi C
    Clin Immunol Immunopathol; 1990 Feb; 54(2):237-46. PubMed ID: 1688523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basophil releasability in patients with hymenoptera venom allergy.
    Radermecker MF; Leclercq MD; Mariz SD; Louis RE
    Int Arch Allergy Immunol; 1993; 101(3):283-7. PubMed ID: 7686798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of basophil histamine releasability between atopic and nonatopic asthmatics.
    Son JW; Kim YK; Chung JW; Lee SR; Cho SH; Min KU; Koh YY; Kim YY
    J Korean Med Sci; 1999 Apr; 14(2):153-8. PubMed ID: 10331560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophil releasability in human hydatidosis.
    Aceti A; Celestino D; Caferro M; Teggi A; Pennica A; Adriani E; Grilli A; Paparo S; Leri O; De Rosa F
    Int Arch Allergy Appl Immunol; 1990; 91(1):111-2. PubMed ID: 1690179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil mediator release in atopic dermatitis.
    Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
    J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.